About Levofloxacin Hemihydrate API
Therapeutic CategoryAnti-Infective
CAS Number
100986-85-4
API Technology
Synthetic
Dose Form
Injectable, Solution/Tablet
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, CEP Submitted, Brazil DMF, EUDMF, Korea DMF, Russia DMF
Related APIs
Ciprofloxacin Hydrochloride
Anti-Infective
Gatifloxacin (Anhydrous)
Anti-Infective
Levofloxacin Hemihydrate
Anti-Infective
Moxifloxacin Hydrochloride (Anhydrous)
Anti-Infective
Posaconazole
Anti-Infective
Terbinafine Hydrochloride
Anti-Infective
Permethrin
Anti-Infective
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
Related Resources
Certificate of Suitability (CEP) granted for Levofloxacin Hemihydrate
Certificate of Suitability (CEP) for the API Levofloxacin Hemihydrate has been granted.
Dr. Reddy’s is among the first companies to receive the CEP from the European Directorate for the Quality of Medicines (EDQM). Together with our expanded manufacturing capacities, this makes us a reliable partner to support your oral and injectable formulations of this anti-infective.
Reach out to our API team at [email protected] or submit an enquiry below to learn more.
Find out more about the product here:
FAQs
Levofloxacin belongs to the class of medicines known as quinolone antibiotics. It is a third-generation fluoroquinolone antibiotic and optically active L-isomer of ofloxacin with antibacterial activity.
-
Treatment of Acute Bacterial Sinusitis and Acute Exacerbation of Chronic Bronchitis when these infections have been adequately diagnosed.
-
Pneumonia - 500 mg orally or IV every 24 hours for 7 to 14 days. Prostatitis- 500 mg orally or IV every 24 hours for 28 days.
-
We offer Crystalline Form
-
Meet with our product experts in one-on-one virtual sessions at https://api.drreddys.com/meet-api-experts or Write to us at [email protected].
Disclaimer
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.